The acquisition includes an initial investment of $35 million and an upfront closing payment of $200 million. By 2029, if the companies reach all targeted regulatory and commercial milestones, the acquisition could cost Cordis up to $1.135 billion in all.

A jury in Georgia has pinned 60% of the blame for a stroke patient’s permanent whole-body paralysis on an ER physician and 40% on a radiologist—while clearing all other clinicians who had a hand in the catastrophic episode of care.

In recent years the world’s supply of helium has raised heightened concerns, and some suppliers recently started to ration the nonrenewable element. 

After programming its EMR to automatically order ultrasound screenings for people at risk of abdominal aortic aneurysms (AAAs), a healthcare system saw a 540% spike in monthly screening exams for the condition over a six-year period.

Ed Nicol, MD, president-elect of the Society of Cardiovascular Computed Tomography, provided us with an exclusive look at how AI is expected to change cardiac imaging.

Researchers tracked outcomes data and imaging results from nearly 4,000 TEER patients, sharing their findings in the Journal of the American College of Cardiology.

Research presented this week at the American Society for Radiation Oncology Annual 2022 Meeting argues for the inclusion of radiation therapy as a standard of care in liver cancer patients who are ineligible for resection and other standard therapies. 

Medtronic says the spinoff is an opportunity to better position both entities and create value.

Suggesting that the standard 10-year age gap screening rule might not be as beneficial as previously assumed, researchers have indicated that women with relatives diagnosed at younger ages should consider different screening criteria.

“These initial actions are needed to start turning the company around," new CEO Roy Jakobs said in a statement.